{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:22:32Z","timestamp":1790302952156,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A72569"],"award-info":[{"award-number":["A72569"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13014-017-0916-7","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T12:41:33Z","timestamp":1510749693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy"],"prefix":"10.1186","volume":"12","author":[{"name":"on behalf of the SCOPE 1 trial management group and collaborators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-2557","authenticated-orcid":false,"given":"Lucy","family":"Wills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhydian","family":"Maggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Staffurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"916_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/1471-2407-11-466","volume":"11","author":"CN Hurt","year":"2011","unstructured":"Hurt CN, Nixon LS, Griffiths GO, Al-Mokhtar R, Gollins S, Staffurth JN, et al. SCOPE1: a randomised phase II\/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer. 2011;11:466. https:\/\/doi.org\/10.1186\/1471-2407-11-466 .","journal-title":"BMC Cancer"},{"key":"916_CR2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","volume":"14","author":"T Crosby","year":"2013","unstructured":"Crosby T, Hurt C, Falk S, Gollins S, Mukherjee S, Staffurth J, et al. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial. Lancet Oncol. 2013;14:627\u201337.","journal-title":"Lancet Oncol"},{"key":"916_CR3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fonc.2013.00311","volume":"3","author":"GS Ibbott","year":"2013","unstructured":"Ibbott GS, Haworth A, Followil DS. Quality assurance for clinical trials. Front Oncol. 2013;3:311. https:\/doi.org\/10.3389\/fonc.2013.00311","journal-title":"Front Oncol"},{"key":"916_CR4","doi-asserted-by":"crossref","DOI":"10.37206\/87","volume-title":"Quality assurance for clinical trials: a primer for physicists. AAPM reports","author":"AJ Olch","year":"2004","unstructured":"Olch AJ. Quality assurance for clinical trials: a primer for physicists. AAPM reports. Madison: Medical physics publishing; 2004. Report no 86. https:\/\/www.aapm.org\/pubs\/reports\/rpt_86.pdf"},{"key":"916_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0959-8049(02)00461-6","volume":"39","author":"VE Kouloulias","year":"2003","unstructured":"Kouloulias VE. Quality Assurance in Radiotherapy. Eur J Cancer. 2003;39:415\u201322.","journal-title":"Eur J Cancer"},{"issue":"3","key":"916_CR6","first-page":"S25","volume":"19","author":"M Button","year":"2007","unstructured":"Button M, Staffurth J, Crosby T. National variations in the treatment of oesophageal carcinoma with chemo-radiotherapy. Clin Oncol. 2007;19(3):S25.","journal-title":"Clin Oncol"},{"key":"916_CR7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.clon.2012.06.006","volume":"24","author":"E Miles","year":"2012","unstructured":"Miles E, Venables K. Radiotherapy quality assurance: facilitation of radiotherapy research and implementation of technology. Clin Oncol. 2012;24:710\u20132. http:\/\/dx.doi.org\/10.1016\/j.clon.2012.06.006","journal-title":"Clin Oncol"},{"key":"916_CR8","unstructured":"ICRU Report 50: prescribing, recording and reporting photon beam therapy. International Commission on Radiological Units and Measurements; 1993."},{"key":"916_CR9","unstructured":"ICRU report 62: prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). International Commission on Radiological Units and Measurements; 1993."},{"key":"916_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/clon.2003.0218","volume":"15","author":"S Mukherjee","year":"2003","unstructured":"Mukherjee S, Aston D, Minette M, Brewster AE, Crosby TDL. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers. Clin Oncol. 2003;15:115\u201320.","journal-title":"Clin Oncol"},{"key":"916_CR11","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1088\/0031-9155\/51\/22\/005","volume":"51","author":"T Kn\u00f6\u00f6s","year":"2006","unstructured":"Kn\u00f6\u00f6s T, Wieslander E, Cozzi L, Brink C, Fogliata A, Albers D, et al. Comparison of dose calculation algorithms for treatment planning in external beam therapy for clinical situations. Phys Med Biol. 2006;51:5785\u2013807.","journal-title":"Phys Med Biol"},{"key":"916_CR12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.radonc.2009.08.036","volume":"93","author":"L Wills","year":"2009","unstructured":"Wills L, Millin A, Paterson J, Crosby T, Staffurth J. The effect of planning algorithms in oesophageal radiotherapy in the context of the SCOPE 1 trial. Radiother Oncol. 2009;93:462\u20137.","journal-title":"Radiother Oncol"},{"key":"916_CR13","doi-asserted-by":"crossref","first-page":"S-673","DOI":"10.1016\/j.ijrobp.2008.06.379","volume":"72","author":"K Ulin","year":"2008","unstructured":"Ulin K, Yorty J, Hanusik R, Urie M, Bosch WR, Apte A, et al. Use of CERR at the quality assurance review center to assess protocol compliance of radiation therapy treatment plans submitted in digital format. Int J Radiat Oncol Biol Phys. 2008;72:S-673.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"916_CR14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijrobp.2012.01.094","volume":"84","author":"S Gwynne","year":"2012","unstructured":"Gwynne S, Spezi E, Wills L, Nixon L, Hurt C, Joseph G, et al. Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pre-trial test case. Int J Radiat Oncol Biol Phys. 2012;84:1037\u201342.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"916_CR15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2011.12.080","volume":"83","author":"J Bekelman","year":"2012","unstructured":"Bekelman J, Deye J, Vikram B, Bentzen S, Bruner D, Curran W Jr, et al. Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials\u2014report of the National Cancer Institute work group on radiotherapy quality assurance. Int J Radiat Oncol Biol Phys. 2012;83:782\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"916_CR16","doi-asserted-by":"crossref","first-page":"20160020","DOI":"10.1259\/bjr.20160020","volume":"89","author":"S Gwynne","year":"2016","unstructured":"Gwynne S, Jones G, Maggs R, Eaton D, Miles E, Staffurth J, et al. Prospective review of radiotherapy trials through implementation of standardized multicentre workflow and IT infrastructure. Br J Radiol. 2016;89:20160020. http:\/\/dx.doi.org\/10.1259\/bjr.20160020","journal-title":"Br J Radiol"},{"key":"916_CR17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.radonc.2016.07.002","volume":"120","author":"E Fokas","year":"2016","unstructured":"Fokas E, Spezi E, Patel N, Hurt C, Nixon L, Chu K, et al. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial. Radiother Oncol. 2016;120:212\u20136.","journal-title":"Radiother Oncol"},{"key":"916_CR18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2009.02.072","volume":"76","author":"F Spoelstra","year":"2010","unstructured":"Spoelstra F, Senan S, Le Pechoux C, Ishikura S, Casas F, Ball D, et al. Variations in target volume delineation for post-operative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study. Int J Radiat Oncol Biol Phys. 2010;76:1106\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"916_CR19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.radonc.2016.04.028","volume":"120","author":"G Eminowicz","year":"2016","unstructured":"Eminowicz G, Rompokos V, Stacey C, McCormack M. The dosimetric impact of target volume delineation variation for cervical cancer radiotherapy. Radiother Oncol. 2016;120:493\u20139.","journal-title":"Radiother Oncol"},{"key":"916_CR20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ijrobp.2006.12.039","volume":"68","author":"S Breen","year":"2007","unstructured":"Breen S, Publicover J, De Silva S, Pond G, Brock K, O\u2019Sullivan B, et al. Intraobserver and Interobserver Variability in GTV Delineation on FDG-PET-CT Images of Head and Neck Cancers Int. J Radiat Oncol Biol Phys. 2007;68:763\u201370.","journal-title":"J Radiat Oncol Biol Phys"},{"key":"916_CR21","doi-asserted-by":"publisher","first-page":"20120398","DOI":"10.1259\/bjr.20120398","volume":"86","author":"S Gwynne","year":"2013","unstructured":"Gwynne S, Spezi E, Sebag-Montefiore D, Mukherjee S, Miles E, Conibear J, et al. Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case. Br J Radiol. 2013;86:20120398. https:\/\/doi.org\/10.1259\/bjr.20120398 .","journal-title":"Br J Radiol"},{"key":"916_CR22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijrobp.2012.01.022","volume":"83","author":"K Goodman","year":"2012","unstructured":"Goodman K, Regine W, Dawson L, Ben-Josef E, Haustermans K, Bosch W, et al. Radiation therapy oncology group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012;83:901\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"916_CR23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"R Myerson","year":"2008","unstructured":"Myerson R, Garofalo M, El Naqa I, Abrams R, Apte A, Bosch W, et al. Elective clinical target volumes for conformal therapy in Anorectal cancer: a radiation therapy group consensus panel contouring atlas. Int J Rad Oncol Biol Phys. 2008;74:824\u201330.","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"916_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.prro.2016.01.006","volume":"6","author":"G Eminowicz","year":"2016","unstructured":"Eminowicz G, Hall-Craggs M, Diez P, McCormack M. Improving target volume delineation in intact cervical carcinoma: Literature review and step-by-step pictorial atlas to aid contouring. Practical Radiat Oncol. 2016;6:203\u201313.","journal-title":"Practical Radiat Oncol"},{"key":"916_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2011.06.026","volume":"100","author":"The FAST Trialists group","year":"2011","unstructured":"The FAST Trialists group. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015). Radiother Oncol. 2011;100:93\u2013100.","journal-title":"Radiother Oncol"},{"issue":"S1","key":"916_CR26","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/S0169-5002(12)70157-5","volume":"75","author":"J Lester","year":"2012","unstructured":"Lester J, Nixon L, Mayles P, Mayles H, Tsang Y, Ionescu A, et al. The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer. Lung Cancer. 2012;75(S1):S51.","journal-title":"Lung Cancer"},{"key":"916_CR27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.clon.2013.01.006","volume":"25","author":"S Gwynne","year":"2013","unstructured":"Gwynne S, Falk S, Gollins S, Wills S, Bateman A, Cummins S, et al. Oesophageal Chemoradiotherapy in the UK \u2013 current and future directions. Clin Oncol. 2013;25:368\u201377.","journal-title":"Clin Oncol"},{"issue":"3","key":"916_CR28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijrobp.2008.04.062","volume":"73","author":"M Button","year":"2009","unstructured":"Button M, Morgan C, Croydon E, Roberts S, Crosby T. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;73(3):818\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"916_CR29","doi-asserted-by":"crossref","unstructured":"M Cominos, M A Mosleh-Shirazi, D Tait, A Henrys, and P Cornes Quantification and reduction of cardiac dose in radical radiotherapy for oesophageal cancer. Br J Radiol 2005;78:936. 1069-1074.","DOI":"10.1259\/bjr\/20742408"},{"key":"916_CR30","doi-asserted-by":"crossref","first-page":"S1. S33","DOI":"10.1016\/j.clon.2004.08.006","volume":"17","author":"L Wills","year":"2005","unstructured":"Wills L, Lewis DG, Passant H, Crosby TDL. A single versus two phase conformal-planning study for Oesophageal radiotherapy. Clin Oncol. 2005;17:S1. S33.","journal-title":"Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-017-0916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T22:02:29Z","timestamp":1603317749000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-017-0916-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1186\/s13014-017-0916-7","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]},"article-number":"179"}}